Scinovex
article Open AccessTop 1% cited

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study

Clinical Infectious Diseases · 2006 · Vol. 43(1) · pp. 25–31
Kevin W. GareyM RegeManjunath P. PaiDana E. MingoKatie J. SudaRobin S. TurpinDavid T. Bearden

Abstract

A delay in the initiation of fluconazole therapy in hospitalized patients with candidemia significantly impacted mortality. New methods to avoid delays in appropriate antifungal therapy, such as rapid diagnostic tests or identification of unique risk factors, are needed.

Antifungal resistance and susceptibilityFungal Infections and StudiesAntibiotic Use and ResistanceFluconazoleMedicineFungemiaInternal medicineCandida glabrataCandida tropicalisCandida parapsilosisCandida albicansRetrospective cohort studyMycosis

MeSH terms

AdultAgedAntifungal AgentsCandidiasisFemaleHumansLength of StayMaleMiddle AgedRetrospective StudiesTime FactorsCohort StudiesFluconazoleFungemia

Funding

  • Enzon Pharmaceuticals
  • University of Houston
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study · Scinovex